John Andrew Lee, PharmD

PPD Drug Development/Clinical Research Fellow

Lee’s research interests include continuous renal replacement therapy dosing strategies, pharmacokinetic/pharmacodynamic considerations for TKIs and PPIs,  design of phase I-III clinical trials, and cardiovascular therapy and genomics.  He is currently studying the biologic and genomic markers of coronary artery disease.

Start Date: 2013
Preceptor: Craig Lee